A protein whose primary role is in the embryonic development of kidneys may play a future role in treating kidney failure. Researchers have successfully treated acute kidney injury in laboratory experiments using cells that were genetically reprogrammed to produce the protein. The research suggests there could be a potential future treatment using such cells delivered intravenously instead of surgically.